Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.


Clinical Trial Description

Participants in this study will be patients at the dermatology clinic who are clinically diagnosed with at least a 2X2 cm patch of melasma on each side of their face (forehead or cheek). Starting at 2 weeks before treatment (week 2), both sides will be pretreated and primed with 4% hydroquinone with, if necessary, 2.5% hydrocortisone cream BID. On the treatment day (2-weeks) and 6-weeks one half of the subject's face will receive glycolic acid peels and the other half of the face will receive 1064nm Q-switch laser. This study is a pilot study designed to determine feasibility of these procedures. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01976273
Study type Interventional
Source Northwestern University
Contact
Status Completed
Phase N/A
Start date October 2013
Completion date January 7, 2015

See also
  Status Clinical Trial Phase
Completed NCT05119413 - Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma Phase 2
Terminated NCT00863278 - Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser Phase 4
Recruiting NCT00927771 - Azelaic Acid Versus Hydroquinone in Melasma Phase 4
Not yet recruiting NCT05930366 - Comparative Evaluation of Microsurgery vs Diode Laser Technique of Gingival Depigmentation N/A
Not yet recruiting NCT05930392 - Comparative Evaluation of Microsurgery vs Conventional Surgical Technique of Gingival Depigmentation N/A
Active, not recruiting NCT01976286 - A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma N/A
Not yet recruiting NCT03585179 - Oral and Topical Tranexamic Acid for the Treatment of Melasma Phase 3